ASPR Medical Supply Chain Interviews

Form Approved

OMB No. 0990-0391

Exp. Date 05/31/2018

Critical Questions

1. Which risks and vulnerabilities are you most concerned about in the current state of the medical supply chain?

2. How would you define success in securing a medical supply chain?

3. What do you see as ASPR’s current role in both the pre- and post-crisis medical supply chain?

4. What are your organization’s current needs and expectations from ASPR, and are those needs met? If not, what could ASPR be doing differently?

5. What does ASPR specifically do in relation to your organization, and how do you see that relationship fitting into the greater supply chain ecosystem?

6. Which other organizations do you view as most critical to medical supply chain security, and what role are they playing?

Additional Questions

1. Do you believe this map capture the major players in the medical supply chain security ecosystem? If not, who are we missing?

2. When you look at the organizations addressing supply chain security, how are roles defined?

   1. Ex. Do organizations work in specific steps of the supply chain? Are they responsible for getting involved when certain types of products are threatened? Are there general functional roles (coordinator/advisor/implementer)?

3. To maximize effectiveness, how do you think roles should be defined?

4. Ideal state – what does a secure medical supply chain look like for [your organization]?

5. How well do you think different players understand their roles with regards to supply chain security?

6. How well do you think different players understand the roles of other organizations with regards to supply chain security?

7. What is the communication and level of engagement like between members of the ecosystem?

   1. Are there different interactions between different types of players? (Ex. Gov’t vs. private sector)

8. What are the key risks threatening medical supply chains?

9. Are there specific steps in the supply chain on which you focus?

10. What are the biggest areas of ambiguity in the ecosystem for supply chain security?

11. How do you define supply chain security for medical goods?

External Organizations

1. How would you characterize your current role in securing medical supply chains?

2. How would you characterize ASPR’s role in preparedness and response to medical supply chains?

3. In a stable state, who is your POC for questions regarding medical preparedness and response?

4. In a crisis, who is your POC for questions regarding medical preparedness and response?

5. How would you characterize the level of interaction and communication with the medical preparedness and response community?

   1. In a stable state

   2. In a crisis

6. What, if any, are the coordination groups you regularly work with in the preparedness and response community? What are the purpose of these groups?

7. Keeping in mind lessons learned from previous medical crises, what would you change about how roles and responsibilities are distributed in regards to medical supply chain security?

8. Is there a particular role that you think ASPR would be well-suited to fill?

9. What risks, if any, do you foresee with ASPR taking on this role?

10. Are there are roles that you believe that ASPR should not play? If so, why?

Next Steps and Wrap Up

1. Is there anything we haven’t talked about yet that you feel would be important for us to consider as we attempt to get a holistic view of the medical supply chain ecosystem?

According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this information collection is 0990-0391. The time required to complete this information collection is estimated to average 60 minutes per response, including the time to review instructions, search existing data resources, gather the data needed, and complete and review the information collection. If you have comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please write to: U.S. Department of Health & Human Services, OS/OCIO/PRA, 200 Independence Ave., S.W., Suite 336-E, Washington D.C. 20201, Attention: PRA Reports Clearance Officer